Tenet Healthcare upgraded to BB- by S&P on improved performance

Published 23/06/2025, 20:28
© Reuters.

Investing.com -- S&P Global Ratings upgraded Tenet Healthcare Corp (NYSE:THC). to ’BB-’ from ’B+’ on Monday, citing the company’s improved credit profile following its multiyear strategic plan.

The rating agency also raised Tenet’s first-lien senior secured debt to ’BB’ from ’BB-’ and its second-lien and unsecured debt to ’B’ from ’B-’.

S&P noted that Tenet has successfully expanded its ambulatory surgery business, rationalized its hospital portfolio, and reduced debt. The ambulatory surgery center (ASC) business now generates about 24% of Tenet’s total consolidated revenue, contributing a higher percentage to overall profitability.

The company’s leverage decreased significantly to 3.5x as of March 31, 2025, from 3.6x as of December 31, 2024, and 5.2x as of December 31, 2023. This improvement was partly due to $5 billion in hospital sales proceeds generated in the past two years, which Tenet used primarily to repay debt and boost cash reserves.

S&P expects Tenet’s leverage to remain around 4x for the next couple of years, based on industry risk, growth prospects, cash flow, and financial policy assumptions.

The rating agency assigned a positive outlook, reflecting its view that Tenet can maintain leverage below 4x while managing potential impacts from pending health policy developments.

S&P believes Tenet’s continued investments in ASC, operating initiatives in acute care, and favorable industry conditions provide a foundation for improved margins and cash flow. The company has indicated that growing its ASC business remains a top priority, though at a slower pace than in recent years.

The rating agency expects Tenet to produce annual free cash flow of $1.2 billion-$1.4 billion in 2025 and 2026, after distributions to noncontrolling interests. How the company deploys these resources will be key to determining whether its credit profile improves further.

S&P noted that while there could be some risk from the Reconciliation bill currently moving through Congress, Tenet has sufficient cushion at this rating level and could implement mitigating measures if needed.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.